- Home
- WMK vs OGN Comparison
WMK vs OGN Comparison
Compare WMK & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMK
- OGN
- Stock Information
- Founded
- WMK 1912
- OGN 1923
- Country
- WMK United States
- OGN United States
- Employees
- WMK N/A
- OGN N/A
- Industry
- WMK Food Chains
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- WMK Consumer Staples
- OGN Health Care
- Exchange
- WMK Nasdaq
- OGN Nasdaq
- Market Cap
- WMK 2.0B
- OGN 2.5B
- IPO Year
- WMK N/A
- OGN N/A
- Fundamental
- Price
- WMK $75.48
- OGN $10.23
- Analyst Decision
- WMK
- OGN Hold
- Analyst Count
- WMK 0
- OGN 4
- Target Price
- WMK N/A
- OGN $18.00
- AVG Volume (30 Days)
- WMK 125.7K
- OGN 3.8M
- Earning Date
- WMK 08-05-2025
- OGN 08-05-2025
- Dividend Yield
- WMK 1.89%
- OGN 0.83%
- EPS Growth
- WMK 6.00
- OGN N/A
- EPS
- WMK 3.99
- OGN 2.88
- Revenue
- WMK $4,810,301,000.00
- OGN $6,294,000,000.00
- Revenue This Year
- WMK N/A
- OGN N/A
- Revenue Next Year
- WMK N/A
- OGN $1.11
- P/E Ratio
- WMK $18.09
- OGN $3.36
- Revenue Growth
- WMK 1.23
- OGN N/A
- 52 Week Low
- WMK $61.58
- OGN $8.01
- 52 Week High
- WMK $90.23
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- WMK 43.38
- OGN 49.95
- Support Level
- WMK $71.40
- OGN $9.73
- Resistance Level
- WMK $76.26
- OGN $10.18
- Average True Range (ATR)
- WMK 1.34
- OGN 0.32
- MACD
- WMK -0.00
- OGN 0.02
- Stochastic Oscillator
- WMK 34.16
- OGN 40.11
About WMK Weis Markets Inc.
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.